219 related articles for article (PubMed ID: 26829472)
1. Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase.
Theodoropoulos PC; Gonzales SS; Winterton SE; Rodriguez-Navas C; McKnight JS; Morlock LK; Hanson JM; Cross B; Owen AE; Duan Y; Moreno JR; Lemoff A; Mirzaei H; Posner BA; Williams NS; Ready JM; Nijhawan D
Nat Chem Biol; 2016 Apr; 12(4):218-25. PubMed ID: 26829472
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase.
Williams NS; Gonzales S; Naidoo J; Rivera-Cancel G; Voruganti S; Mallipeddi P; Theodoropoulos PC; Geboers S; Chen H; Ortiz F; Posner B; Nijhawan D; Ready JM
J Med Chem; 2020 Sep; 63(17):9773-9786. PubMed ID: 32787093
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase.
Winterton SE; Capota E; Wang X; Chen H; Mallipeddi PL; Williams NS; Posner BA; Nijhawan D; Ready JM
J Med Chem; 2018 Jun; 61(12):5199-5221. PubMed ID: 29869888
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of stearoyl CoA desaturase in the skin induces atrophy of the sebaceous glands.
Meingassner JG; Aschauer H; Winiski AP; Dales N; Yowe D; Winther MD; Zhang Z; Stütz A; Billich A
J Invest Dermatol; 2013 Aug; 133(8):2091-4. PubMed ID: 23446987
[No Abstract] [Full Text] [Related]
6. Regulation of stearoyl-coenzyme A desaturase and fatty acid delta-6 desaturase-2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis.
Zouboulis CC; Angres S; Seltmann H
Br J Dermatol; 2011 Aug; 165(2):269-76. PubMed ID: 21457203
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.
Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H
Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-activating lipopeptide-2 and corticotropin-releasing hormone stimulate the inflammatory signalling in human sebocytes through activation of stearoyl-CoA desaturase and fatty acid desaturase 2.
Zouboulis CC; Angres S
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):493-501. PubMed ID: 33131141
[TBL] [Abstract][Full Text] [Related]
9. Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells.
Nashed M; Chisholm JW; Igal RA
Exp Biol Med (Maywood); 2012 Sep; 237(9):1007-17. PubMed ID: 22946088
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.
Lachance N; Gareau Y; Guiral S; Huang Z; Isabel E; Leclerc JP; Léger S; Martins E; Nadeau C; Oballa RM; Ouellet SG; Powell DA; Ramtohul YK; Tranmer GK; Trinh T; Wang H; Zhang L
Bioorg Med Chem Lett; 2012 Jan; 22(2):980-4. PubMed ID: 22209206
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Stearoyl-CoA Desaturase Induces the Unfolded Protein Response in Pancreatic Tumors and Suppresses Their Growth.
Skrypek K; Balog S; Eriguchi Y; Asahina K
Pancreas; 2021 Feb; 50(2):219-226. PubMed ID: 33565799
[TBL] [Abstract][Full Text] [Related]
12. Design, radiosynthesis, and evaluation of radiotracers for positron emission tomography imaging of stearoyl-CoA desaturase-1.
Silvers WC; Cai H; Öz OK; Sun X
Bioorg Med Chem Lett; 2016 Feb; 26(3):924-927. PubMed ID: 26778147
[TBL] [Abstract][Full Text] [Related]
13. A Phase 1 Randomized, Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A Desaturase 1 Under Occluded and Nonoccluded Conditions.
Brigandi RA; Zhu J; Murnane AA; Reedy BA; Shakib S
Clin Pharmacol Drug Dev; 2019 Apr; 8(3):270-280. PubMed ID: 30650256
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series.
Lachance N; Guiral S; Huang Z; Leclerc JP; Li CS; Oballa RM; Ramtohul YK; Wang H; Wu J; Zhang L
Bioorg Med Chem Lett; 2012 Jan; 22(1):623-7. PubMed ID: 22101133
[TBL] [Abstract][Full Text] [Related]
15. Protein engineering: Regulatory perspectives of stearoyl CoA desaturase.
Kamal S; Saleem A; Rehman S; Bibi I; Iqbal HMN
Int J Biol Macromol; 2018 Jul; 114():692-699. PubMed ID: 29605251
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells.
Hess D; Chisholm JW; Igal RA
PLoS One; 2010 Jun; 5(6):e11394. PubMed ID: 20613975
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer.
Oatman N; Dasgupta N; Arora P; Choi K; Gawali MV; Gupta N; Parameswaran S; Salomone J; Reisz JA; Lawler S; Furnari F; Brennan C; Wu J; Sallans L; Gudelsky G; Desai P; Gebelein B; Weirauch MT; D'Alessandro A; Komurov K; Dasgupta B
Sci Adv; 2021 Feb; 7(7):. PubMed ID: 33568479
[TBL] [Abstract][Full Text] [Related]
18. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H
Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772
[TBL] [Abstract][Full Text] [Related]
19. Expression of lipogenic factors galectin-12, resistin, SREBP-1, and SCD in human sebaceous glands and cultured sebocytes.
Harrison WJ; Bull JJ; Seltmann H; Zouboulis CC; Philpott MP
J Invest Dermatol; 2007 Jun; 127(6):1309-17. PubMed ID: 17363919
[TBL] [Abstract][Full Text] [Related]
20. Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.
Oballa RM; Belair L; Black WC; Bleasby K; Chan CC; Desroches C; Du X; Gordon R; Guay J; Guiral S; Hafey MJ; Hamelin E; Huang Z; Kennedy B; Lachance N; Landry F; Li CS; Mancini J; Normandin D; Pocai A; Powell DA; Ramtohul YK; Skorey K; Sørensen D; Sturkenboom W; Styhler A; Waddleton DM; Wang H; Wong S; Xu L; Zhang L
J Med Chem; 2011 Jul; 54(14):5082-96. PubMed ID: 21661758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
